Biomaterial Database

Prolonged survival times of allogeneic skin grafts using somatic cell hybrids. 1979

T Nishihira, and M Tan, and H Ishii, and M Kasai, and T Tachibana

UI	MeSH Term	Description	Entries
D007165	Immunosuppression Therapy	Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs.	Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007518	Isoantibodies	Antibodies from an individual that react with ISOANTIGENS of another individual of the same species.	Alloantibodies
D003602	Cytotoxicity, Immunologic	The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement.	Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D006085	Graft Survival	The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host.	Graft Survivals,Survival, Graft,Survivals, Graft
D006183	H-2 Antigens	The major group of transplantation antigens in the mouse.	H2 Antigens,Antigens, H-2,Antigens, H2,H 2 Antigens
D006822	Hybrid Cells	Any cell, other than a ZYGOTE, that contains elements (such as NUCLEI and CYTOPLASM) from two or more different cells, usually produced by artificial CELL FUSION.	Somatic Cell Hybrids,Cell Hybrid, Somatic,Cell Hybrids, Somatic,Cell, Hybrid,Cells, Hybrid,Hybrid Cell,Hybrid, Somatic Cell,Hybrids, Somatic Cell,Somatic Cell Hybrid
D000818	Animals	Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA.	Animal,Metazoa,Animalia
D000918	Antibody Specificity	The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site.	Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D014184	Transplantation, Homologous	Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals.	Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D016038	Skin Transplantation	The grafting of skin in humans or animals from one site to another to replace a lost portion of the body surface skin.	Dermatoplasty,Grafting, Skin,Transplantation, Skin,Dermatoplasties,Graftings, Skin,Skin Grafting,Skin Graftings,Skin Transplantations,Transplantations, Skin

Related Publications

T Nishihira, and M Tan, and H Ishii, and M Kasai, and T Tachibana

Prolonged survival time of allogeneic skin grafts in host pretreated with somatic cell hybrids and prednisolone.

September 1979, The Tohoku journal of experimental medicine,

T Nishihira, and M Tan, and H Ishii, and M Kasai, and T Tachibana

Prolonged survival of allogeneic mouse skin grafts following preservation.

January 1980, Israel journal of medical sciences,

T Nishihira, and M Tan, and H Ishii, and M Kasai, and T Tachibana

Prolonged survival of allogeneic guinea pig skin grafts by indomethacin.

January 1968, Surgical forum,

T Nishihira, and M Tan, and H Ishii, and M Kasai, and T Tachibana

Prolonged survival of rhesus fetal skin grafts on nonimmunosuppressed allogeneic hosts.

January 1986, Transplantation,

T Nishihira, and M Tan, and H Ishii, and M Kasai, and T Tachibana

Survival of sub-optimal cadaver renal grafts with prolonged cold ischaemic times using cyclosporin.

January 1987, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,

T Nishihira, and M Tan, and H Ishii, and M Kasai, and T Tachibana

Prolonged survival of reconstituted skin grafts without immunosuppression.

January 1990, The Journal of burn care & rehabilitation,

T Nishihira, and M Tan, and H Ishii, and M Kasai, and T Tachibana

Survival of allogeneic cells in cultured organotypic skin grafts.

July 1995, Plastic and reconstructive surgery,

T Nishihira, and M Tan, and H Ishii, and M Kasai, and T Tachibana

Comparative mapping using somatic cell hybrids.

November 1976, In vitro,

T Nishihira, and M Tan, and H Ishii, and M Kasai, and T Tachibana

Gene mapping using somatic cell hybrids.

January 1997, Methods in molecular biology (Clifton, N.J.),